Indaptus Therapeutics Inc...

NASDAQ: INDP · Real-Time Price · USD
7.58
-0.23 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
7.30
-3.69%
After-hours: Aug 15, 2025, 05:43 PM EDT

Indaptus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-16.96M -15.75M -15.02M -14.89M -15.75M -14.98M -15.42M -15.08M -14.62M -15.21M -14.32M -13.88M -3.25M -10.46M -7.71M -5.27M -8.43M 2.62M
Depreciation & Amortization
n/a n/a 735.00 1.05K 1.38K 1.7K 1.28K 1.28K 1.36K 1.57K 1.78K 2K -1.18M 1.72K 1.4K 1.08K 567.85K -609.93K
Stock-Based Compensation
1.17M 1.77M 2.31M 2.75M 3.07M 3.01M 2.97M 2.86M 2.68M 2.85M 2.96M 2.99M 3.04M 2.32M 1.51M 859.54K -508.04K -695.56K
Other Working Capital
-771.81K -407.34K -81.8K 873.27K 237.13K 163.37K 154.09K 254.04K -15.79K -306.14K -264.08K -327.62K -521.15K -510.47K -1.59M -1.84M 1.15M 1.14M
Other Non-Cash Items
1.03M n/a n/a -903.88K -1.04M -1.77M -1.9M -1.1M -967.7K -239.29K -134.21K -10.57M -3.31M -24.16K 2.12M 12.65M 10.91M 7.63M
Deferred Income Tax
n/a n/a n/a 1.05M 1.05M 1.62M 1.62M 567.27K 567.27K n/a n/a 10.53M n/a n/a n/a -10.53M -5.55M -5.55M
Change in Working Capital
-212.59K 541.88K 392.25K 597.26K 48.88K -134.87K -536.88K -263.98K -1.54M -2.33M -1.58M -3.49M -5.46M -5.42M -5.09M -4.3M 1.21M 1.39M
Operating Cash Flow
-14.97M -13.43M -12.32M -11.4M -12.62M -12.25M -13.28M -13.01M -13.88M -14.92M -13.08M -14.41M -10.16M -13.58M -11.29M -8.71M -3.9M 2.67M
Capital Expenditures
-3.09 1.16 1.16 8.91 8.91 4.66 4.66 -3.94K -1.94M 1.03M -1.94M -1.93M n/a -2.97M n/a -3.85K 3K 2K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -1.18K -2.53K -6.42K 166.14K 629.78K 631.13K 635.02K 462.47K n/a n/a n/a
Purchase of Investments
n/a n/a n/a 24.44K 130.46K 240.69K -6.62M -12.52M -17.57M -33.49M -29.6M -23.72M -18.78M -2.97M n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a -85.53K 6.91M 14.91M 23.91M 35M 29.94M 21.94M 12.94M 1.94M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -106.02K -216.25K -214.11K -208.99K 1.9M 1.99M 2.16M 2.6M 604.49K 620.3K 447.75K n/a -772K -772K
Investing Cash Flow
n/a n/a n/a -61.08K 6.94M 14.94M 17.08M 22.26M 12.32M -11.49M -16.43M -21.09M -18.16M -2.35M 447.75K -3.85K -769K -770K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.54M -742.71K -762.7K -429.52K -21.48K -20K n/a n/a n/a n/a n/a 363.06K 42.38M 44.16M 47.83M 47.46M 5.38M 3.61M
Financial Cash Flow
13.83M 7.58M 4.75M 2.95M 354.11K 316.05K n/a n/a n/a n/a n/a 363.06K 37.48M 44.66M 48.34M 47.97M 1.42M -5.77M
Net Cash Flow
-1.14M -5.85M -7.58M -8.58M -5.4M 2.94M 3.74M 9.25M -1.56M -26.41M -29.51M -35.14M -3.73M 28.73M 37.49M 39.26M 4.19M -9.31M
Free Cash Flow
-14.97M -13.43M -12.32M -11.53M -12.75M -12.38M -13.41M -13.02M -15.82M -13.89M -15.02M -16.34M -10.16M -16.55M -11.29M -8.71M -3.9M 2.67M